Amaranth Gets Claim Back, Loses Another, In JPMorgan Appeal

Nov 9 2009 | 12:32pm ET

A court has reinstated one of Amaranth Advisors’ claims against JPMorgan Chase.

The collapsed hedge fund sued its clearing broker two years ago, accusing it of trying to force it into default. But a New York state court last year tossed Amaranth’s claim of tortuous interference, leaving just a breach of contract claim.

But an appeals court has restored the former allegation based on a statement allegedly made by two JPMorgan executives to Citadel Investment Group, which bought up two-thirds of its portfolio for pennies on the dollar. Steve Black and Bill Winters, the heads of JPMorgan’s investment bank, allegedly told Citadel founder Kenneth Griffin that Amaranth was “not as solvent as they are telling you they are,” and wouldn’t be able to find another taker for its poisonous portfolio, which had lost $6 billion on bad natural gas bets. Amaranth claims that $2.5 billion of those losses were the result of the cash concession it had to pay JPMorgan to take on its energy portfolio.

The ruling was not a complete victory for Amaranth: The hedge fund saw its breach of contract claim tossed by the appeals court, meaning it’s still got only one claim against JPMorgan. The collapsed hedge fund said it was “reviewing out options with regard to the dismissal of the breach claim.”

Amaranth claims that JPMorgan refused to execute a trade transferring its natural gas positions to Goldman Sachs so that it could take the portfolio for itself. The hedge fund is seeking $1 billion in damages.


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

DarcMatter: The Top Trends in Alternative Investments for 2017

Jan 13 2017 | 8:22pm ET

The $7 trillion alternative investments industry is poised for continued growth...

 

From the current issue of

The healthcare sector went on a tear beginning in 2011, thanks in large part to the passage of the Affordable Care Act and its impending implementat